Search - tctmd.com

Displaying 1 - 20 of 41

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 30, 2024

Presentation TCT 2024

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Presenter: Frederic Bouisset

October 30, 2024

Presentation TCT 2024

Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

Presenter: Grzegorz Kaluza

October 30, 2024

Presentation TCT 2024

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

Presenter: Sahil Parikh

October 30, 2024

Presentation TCT 2024

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

Presenter: Han Chen

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

Presenter: Francesco Amata

October 29, 2024

Presentation TCT 2024

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

Presenter: Ryan Wallace

October 29, 2024

Presentation TCT 2024

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

Presenter: Stefano Galli

October 29, 2024

Presentation TCT 2024

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 29, 2024

Presentation TCT 2024

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

Presenter: Marta Mazur

October 29, 2024

Presentation TCT 2024

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

Presenter: KOTARO MIYASHITA

October 29, 2024

Presentation TCT 2024

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Presenter: Brian DeRubertis

October 28, 2024

Presentation TCT 2024

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

Presenter: Han Su Park

October 28, 2024

Presentation TCT 2024

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Presenter: Lawrence Garcia

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Advertisement

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

TCT 1219: Should We Treat Bioresorbable Scaffold Restenosis in the Same Manner as We Did During the Era of Metallic Drug-Eluting Stents?

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

TCT 370: Clinical Safety and Angiographic Performance of the Fantom Encore Bioresorbable Scaffold: Insights From an Italian Center

TCT 367: Impact of Optical Coherence Tomography Guidance During Bioresorbable Scaffold Implantation: Decision-Making and Post-Procedure Outcomes

TCT 368: Coronary Physiology After Drug-Eluting Absorbable Metallic Scaffold

TCT 366: Preliminary 24-Month Results of the Magmaris Resorbable Magnesium Scaffold (RMS) in Long and Multivessel Disease: Data From the Italian IT-MASTERS Registry

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 365: Ten-Year Outcomes Following Bioresorbable Vascular Scaffold Implantation in Patients With De Novo Occlusive Coronary Artery Disease

TCT 369: Functional Hemodynamic Assessment of a Novel Endoluminal Fibrillated Polymeric Scaffold up to Full Resorption Within 12 Months in a Preclinical In-Vivo Setting

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

TCT 1011: Drug-Eluting Stent or Bioresorbable Vascular Scaffold for Preventive PCI: Post-Hoc Analysis From the PREVENT Trial

Scaffolds for the SFA: Will We Ever Have Anything Better Than Nitinol?

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content